Now you can see non-English news...
2020-11-10T01:17:43.614Z
It is the drug with monoclonal antibodies from the pharmaceutical company Eli Lilly. 11/09/2020 21:51 Clarín.com World Updated 11/09/2020 21:51 The United States authorized the emergency use of Eli Lilly's experimental drug to treat mild and moderate cases of COVID-19. It is a monoclonal antibody treatment that is applied intravenously. The pharmaceutical company said it could produce more than a million doses of the treatment by the end of the year. News in development. AFG
11/09/2020 21:51
Clarín.com
World
Updated 11/09/2020 21:51
The United States authorized the emergency use of Eli Lilly's experimental drug to treat mild and moderate cases of COVID-19.
It is a monoclonal antibody treatment that is applied intravenously.
The pharmaceutical company said it could produce more than a million doses of the treatment by the end of the year.
News in development.
AFG
© Communities 2019 - Privacy
The information on this site is from external sources that are not under our control.
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/TCAGVOBDXCALDXGXIQKYSLIXGE.jpg)